Bookmarks
Beta-blocker Stratification using MRI to assess portal pressure (B-SMaRT)
Population Size
46
People
Years
2016
Associated BioSamples
None/not available
Geographic coverage
Lead time
Variable
Summary
Documentation
Beta-blocker Stratification using quantitative MRI techniques to assess portal pressure and Response to Treatment in patients with portal hypertension (B-SMaRT study).
To provide proof of concept that quantitative haemodynamic MRI markers can stratify the efficacy of carvedilol to lower clinically significant portal hypertension in patients with cirrhosis.
Descriptive sequential pilot study of patients with cirrhosis, portal pressure measurement, research MRI (at 3T) and endoscopy with outcomes with repeat measures in those who are given Carvedilol.
Dataset type
Dataset population size
Keywords
Observations
Observed Node | Disambiguating Description | Measured Value | Measured Property | Observation Date |
|---|---|---|---|---|
Persons |
| 46 | COUNT | 01 Aug 2016 |
Provenance
Purpose of dataset collection
Patient pathway description
Biological sample availability
Details
Publishing frequency
Version
Modified
03/10/2025
Coverage
Start date
01/08/2016
Time lag
Minimum age range
Maximum age range
Accessibility
Language
Alignment with standardised data models
Controlled vocabulary
Format
Data Access Request
Time to dataset access
Access service description
Jurisdiction
Data use limitation
Data Controller
Data Processor